Douglas Stafford

Douglas Stafford has 30 years’ experience in biomedical business development and executive management in venture and public companies; currently, he is President and Chief Executive Officer of Pantherics Incorporated and Director of the Milwaukee Institute for Drug and Discovery. Prior to his current roles, he held senior management positions at Baxter Healthcare Corporation in manufacturing operations, product development, and quality systems. He led product development, regulated operations, general management, and financing of several entrepreneurial ventures, including positions of Chief Operating Officer and later President of Ophidian Pharmaceuticals, founder and President of Life Sciences Development Corp., and Executive Vice President of GenExel-Sein, Inc. He has formed biomedical product development partnerships and technology licenses (including; Lilly, Pfizer, Allergan, DoD, and more than 80 universities), and organized drug clinical trials.